Gainers
ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.
United Maritime Corporation (the "Company" or "United") (NASDAQ:USEA), announced today that it has entered into definitive agreements with an unaffiliated third party for the sale of two Aframax